dGenThera
Durham, United States (US) · Health and Medical
We built this page from public sources.
Do you work at dGenThera?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
dGenThera is a next-generation targeted radiotherapeutics company based in Durham, North Carolina, focused on developing innovative theranostic agents for precision oncology.We are dedicated to advancing a differentiated pipeline of small molecules and bioligand-tag conjugates, leveraging Astatine-211 (211At), Iodine-131 (131I), and Fluorine-18 (18F) to deliver exquisitely matched therapies.Our proprietary chemistry, including stabilized carbon-halogen bonds, enables accurate dosimetry, improved patient stratification, and reduced off-target toxicity.
Overview
We are dedicated to advancing a differentiated pipeline of small molecules and bioligand-tag conjugates, leveraging Astatine-211 (211At), Iodine-131 (131I), and Fluorine-18 (18F) to deliver exquisitely matched therapies.
Our proprietary chemistry, including stabilized carbon-halogen bonds, enables accurate dosimetry, improved patient stratification, and reduced off-target toxicity. dGenThera’s technology offers a significant advancement in targeted radiotherapy, with promising results demonstrated in preclinical studies, including tumor growth inhibition in breast cancer xenograft models. We are committed to transforming cancer treatment through innovative, safe, and effective radiotherapeutics.
Contact Details
Durham, United States (US)
Founded
2023
Company Type
Private Limited Company
Employees
2-10
Categories
Products
Companies teams usually look at after dGenThera
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.